“Diabetes and kidney disease are not separate problems — they are the same vascular disease seen in two different organs, progressing in lockstep, and leading eventually to the same place: my operating theatre for a dialysis access procedure.”
By Dr. Rahul Agarwal | Consultant Vascular & Endovascular Surgeon, CARE Hospitals, Banjara Hills, Hyderabad
Diabetic nephropathy — kidney damage caused by diabetes — is the leading cause of chronic kidney disease (CKD) and dialysis dependence worldwide. It is also one of the most preventable. Understanding the vascular connection between diabetes and kidney disease — and when the vascular surgeon becomes essential — is crucial knowledge for every diabetic patient.
🨘 How Diabetes Damages the Kidneys
The kidney filters blood through approximately one million tiny filtration units called glomeruli. Each glomerulus is a tuft of capillaries — and like all capillaries in the body, they are profoundly vulnerable to the effects of chronic hyperglycaemia:
- Glomerular basement membrane thickening: Glycation of structural proteins thickens the membrane, initially increasing filtration but progressively reducing it
- Mesangial expansion: Glucose-driven growth factors stimulate excess matrix protein deposition, physically compressing and destroying capillary loops
- Endothelial dysfunction: Glomerular endothelial cells lose their protective negative charge, allowing albumin to leak into urine (microalbuminuria — the earliest detectable sign)
- Afferent arteriole dilation + efferent arteriole constriction: Early diabetes causes glomerular hyperfiltration through this haemodynamic imbalance — initially manifesting as elevated eGFR, before the inevitable decline
- Inflammation and fibrosis: Progressive scarring of glomeruli and tubulo-interstitial tissue replaces functional kidney tissue with non-functioning scar
📊 The Stages of Diabetic Kidney Disease
- Hyperfiltration (eGFR >120): Early diabetes; no symptoms; detectable only by eGFR measurement
- Microalbuminuria (30–300 mg/day): First clinical sign; largely reversible with excellent BP and glucose control; ACE inhibitors/ARBs are renoprotective at this stage
- Macroalbuminuria (>300 mg/day): Established nephropathy; eGFR begins declining; progression to CKD increasingly likely
- CKD Stage 3–4 (eGFR 15–60): Significant kidney impairment; cardiovascular risk very high; this is when I first see these patients for dialysis access planning
- CKD Stage 5 / ESRD (eGFR <15): Dialysis or transplant required; AV fistula surgery planned and performed
🔗 Where Vascular Surgery Enters
When diabetic nephropathy progresses to end-stage renal disease (ESRD), haemodialysis becomes necessary. Haemodialysis requires reliable, high-flow access to the bloodstream — and the gold-standard access is the AV fistula, created by a vascular surgeon.
The challenge: diabetic patients often have the worst veins for fistula creation. Medial arterial calcification from diabetes makes arteries stiff and non-compliant. Micro and macrovascular disease compromises the vessels we rely on. Diabetic nephropathy patients should ideally be referred to a vascular surgeon at eGFR 20–25 for early vein mapping and access planning — giving the best chance of a successful, mature fistula by the time dialysis starts.
🛡️ Prevention: What Actually Slows Diabetic Kidney Disease
- HbA1c below 7%: Most powerful intervention; reduces nephropathy progression by ~35% per 1% reduction
- BP below 130/80 mmHg: ACE inhibitors and ARBs have additional renoprotective effects beyond BP lowering
- SGLT2 inhibitors: New class of diabetes medications (empagliflozin, dapagliflozin) with proven nephroprotective effects independent of glucose lowering — now first-line in diabetic kidney disease
- Annual microalbuminuria screening: Catches nephropathy at its earliest reversible stage
- Avoid nephrotoxins: NSAIDs, high-dose contrast, aminoglycosides all accelerate CKD in diabetics
❓ Frequently Asked Questions
I have diabetes and my eGFR is 55. Am I heading toward dialysis?
An eGFR of 55 is CKD Stage 3a. With excellent glucose and BP control, many patients stabilise at this level and never require dialysis. However, the risk is real — particularly if HbA1c and BP are not well controlled. Ask your doctor about SGLT2 inhibitors, ensure ACE/ARB coverage, and get nephrology review if not already under their care.
My nephrologist mentioned AV fistula surgery. When should I see a vascular surgeon?
As soon as your eGFR is in the 20–25 range (CKD Stage 4). Earlier is better — allowing time for vein mapping, surgical planning, and fistula maturation before dialysis starts. If your nephrologist hasn’t referred you yet at this stage, ask explicitly.
🔑 Key Insights: Diabetic nephropathy is the #1 cause of dialysis worldwide. The mechanism is glomerular capillary destruction through hyperglycaemia-driven glycation, hyperfiltration, and fibrosis. Microalbuminuria is the earliest detectable sign — and the most reversible stage. SGLT2 inhibitors, ACE inhibitors, and HbA1c below 7% are the pillars of renal protection. At eGFR 20–25, see a vascular surgeon for dialysis access planning.
📚 Related Reading
- Dialysis Access & AV Fistula Surgery
- How Diabetes Silently Damages Your Blood Vessels
- When Should a CKD Patient See a Vascular Surgeon?
👨⚕️ About the Author
Dr. Rahul Agarwal is a Consultant Vascular & Endovascular Surgeon at CARE Hospitals, Banjara Hills, Hyderabad. He provides dialysis access surgery for patients with diabetic nephropathy and CKD, and works closely with nephrologists and diabetologists to ensure patients reach dialysis with functioning, well-matured access.
Medical Disclaimer: This article is intended for general patient education only and does not constitute individualised medical advice. Always consult a qualified medical professional for diagnosis and treatment specific to your condition.